Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Diffuse panbronchiolitis: efficacy of low-dose erythromycin

J Trédaniel, D Cazals-Hatem, G Zalcman

    Respiratory Medicine
    |July 1, 1994
    PubMed
    Summary

    No abstract available in PubMed .

    Related Experiment Videos

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Four-Year Outcomes of First-Line Nivolumab Plus Ipilimumab for 6 Months Versus Continuation in Patients With Advanced NSCLC: Results of the Randomized IFCT-1701 "DICIPLE" Phase III Trial.

    Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer·2026
    Same author

    [The role of the pulmonologist in the therapeutic strategy for stage I bronchopulmonary cancers?]

    Revue des maladies respiratoires·2024
    Same author

    YAP/TEAD involvement in resistance to paclitaxel chemotherapy in lung cancer.

    Molecular and cellular biochemistry·2024
    Same author

    Burden of comorbidities: Osteoporotic vertebral fracture during non-small cell lung cancer - the BONE study.

    European journal of cancer (Oxford, England : 1990)·2024
    Same author

    [Non-infectious respiratory emergencies in patients with cancer].

    Revue des maladies respiratoires·2023
    Same author

    Final results of the IFCT-0803 study, a phase II study of cetuximab, pemetrexed, cisplatin, and concurrent radiotherapy in patients with locally advanced, unresectable, stage III, non-squamous, non-small-cell lung cancer.

    Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique·2022